Bionaut Labs Press Releases
Bionaut Labs Closes $43M In Series B Led By Khosla Ventures To Advance First-In-Class Microrobotic Technology And Remove Barriers To Treat Rare And Debilitating Diseases
Dandy Walker Alliance To Collaborate With Bionaut Labs
Bionaut Labs And Candel Therapeutics Announce Strategic Collaboration In Precision Targeted Delivery Of Oncolytic Viral Immunotherapies
FDA Grants Humanitarian Use Device Designation To Bionaut Labs For Treatment Of Dandy Walker Syndrome
FDA Grants Bionaut Labs Orphan Drug Designation To BNL-101 For The Treatment Of Malignant Gliomas In Pediatric And Adult Patients
Bionaut Labs Debuts From Stealth Mode To Accelerate Development Of New Precision Treatment Modality For Brain Disorders
Newsroom - Exclusive: Bionaut Labs Raises An Extension Round In Preparation For Micro-Robot Clinical Trials
Bionaut Selected As A Norrsken Impact/100 Company
Bionaut Labs Profiled On "Hope And Help Happen Here" Podcast
Technology - Bionaut Micro-Technology
Magnetic Propulsion
Precision magnetic propulsion allows Bionauts to track on complex 3D trajectories with accuracy.
Safety
Size, precision and wireless control yield an unparalleled safety profile.
Access
Direct wireless access to previously inaccessible deep locations in the body.
Applications
Microsurgical
The Bionaut Platform is designed to overcome key limitations of conventional neurosurgery, enabling access to areas that are typically difficult to reach.
Diagnostic, Biological Sensing/Monitoring, Stimulatory
The Bionaut Platform allows precise drug delivery to treat conditions at the site of disease.
Conclusion
Treat localized disease, locally. We remove the barriers of localized treatment & detection of diseases.